ANI Pharmaceuticals reported $608.35M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
AbbVie USD 64.53B 4.19B Mar/2025
ANI Pharmaceuticals USD 608.35M 3.28M Jun/2025
Aurora Cannabis CAD 36.3M 3.89M Jun/2025
Canopy Growth CAD 289M 178.93M Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Novartis USD 24.06B 1.13B Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Sun Pharmaceuticals INR 3.58B 99.6M Mar/2025
Teva Pharmaceutical Industries USD 16.76B 533M Jun/2025